Page 2 - துறை ஆஃப் மருத்துவ தொற்றுநோய் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MRI screening and targeted biopsies could reduce overdiagnoses of prostate cancer Most countries have not introduced nationwide prostate-cancer screening, as current methods result in overdiagnoses and excessive and unnecessary biopsies. A new study by researchers at Karolinska Institutet in Sweden, which is published in The New England Journal of Medicine, indicates that screening by magnetic resonance imaging (MRI) and targeted biopsies could potentially cut overdiagnoses by half. The results are presented today at the European Association of Urology Congress. Our results from a large, randomised study show that modern methods for prostate cancer screening maintain the benefits of screening, while decreasing the harms substantially. This addresses the greatest barrier to the introduction of nationwide screening, explains Tobias Nordström, associate professor of Urology at the Department of Clinical Sciences, Danderyd Hospital at Karolinska Institutet, who is in charge of the

Tobias nordstrKarolinska institutetMartin eklundHendrik van poppelEmily hendersonEuropean association of urologyDepartment of clinical sciencesEuropean association of urology congressEuropean commissionDepartment of medical epidemiologyNew england journalEuropean associationClinical sciencesDanderyd hospitalMedical epidemiologyStockholm county